Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Property, Plant & Equipment (Net) history
Currency unavailable · from the balance sheet
No Property, Plant & Equipment (Net) data reported for this period type.
Property, Plant & Equipment (Net) vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $14.07M USD | +12.7% | +7.2% | 3.2% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $11.85M USD | +8.9% | +237.6% | 2.4% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $8.07M USD | +31.8% | +58.8% | 3.1% |
| Mar 2026 | $6.23M USD | -13.3% | -2.6% | 1.5% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $3.63M USD | -8.3% | +975.5% | 0.9% |
| Mar 2026 | $580K USD | -17.7% | +85.6% | 0.2% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $390K USD | -79.3% | -65.0% | 0.3% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -8.3% | +58.8% | 1.5% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.